The DOI matches its Crossref record; 642 of the 642 references it cites were found in a registry or an index.
How does adenosine control neuronal dysfunction and neurodegeneration?
Abstract
The adenosine modulation system mostly operates through inhibitory A 1 (A 1 R) and facilitatory A 2A receptors (A 2A R) in the brain. The activity‐dependent release of adenosine acts as a brake of excitatory transmission through A 1 R, which are enriched in glutamatergic terminals. Adenosine sharpens salience of information encoding in neuronal circuits: high‐frequency stimulation triggers ATP release in the ‘activated’ synapse, which is locally converted by ecto‐nucleotidases into adenosine to selectively activate A 2A R; A 2A R switch off A 1 R and CB1 receptors, bolster glutamate release and NMDA receptors to assist increasing synaptic plasticity in the ‘activated’ synapse; the parallel engagement of the astrocytic syncytium releases adenosine further inhibiting neighboring synapses, thus sharpening the encoded plastic change. Brain insults trigger a large outflow of adenosine and ATP, as a danger signal. A 1 R are a hurdle for damage initiation, but they desensitize upon prolonged activation. However, if the insult is near‐threshold and/or of short‐duration, A 1 R trigger preconditioning, which may limit the spread of damage. Brain insults also up‐regulate A 2A R, probably to bolster adaptive changes, but this heightens brain damage since A 2A R blockade affords neuroprotection in models of epilepsy, depression, Alzheimer's, or Parkinson's disease. This initially involves a control of synaptotoxicity by neuronal A 2A R, whereas astrocytic and microglia A 2A R might control the spread of damage. The A 2A R signaling mechanisms are largely unknown since A 2A R are pleiotropic, coupling to different G proteins and non‐canonical pathways to control the viability of glutamatergic synapses, neuroinflammation, mitochondria function, and cytoskeleton dynamics. Thus, simultaneously bolstering A 1 R preconditioning and preventing excessive A 2A R function might afford maximal neuroprotection. image The main physiological role of the adenosine modulation system is to sharp the salience of information encoding through a combined action of adenosine A 2A receptors (A 2A R) in the synapse undergoing an alteration of synaptic efficiency with an increased inhibitory action of A 1 R in all surrounding synapses. Brain insults trigger an up‐regulation of A 2A R in an attempt to bolster adaptive plasticity together with adenosine release and A 1 R desensitization; this favors synaptotocity (increased A 2A R) and decreases the hurdle to undergo degeneration (decreased A 1 R). Maximal neuroprotection is expected to result from a combined A 2A R blockade and increased A 1 R activation. This article is part of a mini review series: “Synaptic Function and Dysfunction in Brain Diseases”.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Assaife‐Lopes, N., Sousa, V. C., Pereira, D. B., Ribeiro, J. A., Chao, M. V., & Sebastião, A. M. (2010) · Journal of Neuroscience · doi:10.1523/jneurosci.5695-09.2010 · Cited by 53
RetractedATP mediates rapid microglial response to local brain injury in vivo
Davalos, D., Grutzendler, J., Yang, G., Kim, J. V., Zuo, Y., Jung, S., Littman, D. R., Dustin, M. L., & Gan, W.-B. (2005) · Nature Neuroscience · doi:10.1038/nn1472 · Cited by 3,913
Excitatory Amino Acids as a Final Common Pathway for Neurologic Disorders
Epstein, F. H., Lipton, S. A., & Rosenberg, P. A. (1994) · New England Journal of Medicine · doi:10.1056/nejm199403033300907 · Cited by 2,658
Fredholm, B. B., Bättig, K., Holmén, J., Nehlig, A., & Zvartau, E. E. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01396-6 · Cited by 2,624 · cited 2×
“In fact, the main molecular mechanism of action established for non-toxic doses of caffeine is the antagonism (not the agonism) of adenosine receptors (Fredholm et al., 1999), although recent exciting new data proposed”
BackgroundTripartite synapses: glia, the unacknowledged partner
Araque, A., Parpura, V., Sanzgiri, R. P., & Haydon, P. G. (1999) · Trends in Neurosciences · doi:10.1016/s0166-2236(98)01349-6 · Cited by 2,529
Choi, D. W. (1992) · Journal of Neurobiology · doi:10.1002/neu.480230915 · Cited by 2,314
The 2.6 Angstrom Crystal Structure of a Human A 2A Adenosine Receptor Bound to an Antagonist
Jaakola, V.-P., Griffith, M. T., Hanson, M. A., Cherezov, V., Chien, E. Y. T., Lane, J. R., IJzerman, A. P., & Stevens, R. C. (2008) · Science · doi:10.1126/science.1164772 · Cited by 1,781
Synaptic Dysfunction in Depression: Potential Therapeutic Targets
Duman, R. S., & Aghajanian, G. K. (2012) · Science · doi:10.1126/science.1222939 · Cited by 1,651 · cited 1×
“…a dysfunction and damage of synapses, which is one of the earliest alterations found in different neurodegenerative disorders ranging from Alzheimer’s disease to depression (reviewed in Li et al. 2003; Coleman et al. 2004; Wishart et al. 2006; Cunha and Agostinho 2010; Duman and Aghajanian 2012).”
BackgroundThe Role and Regulation of Adenosine in the Central Nervous System
Dunwiddie, T. V., & Masino, S. A. (2001) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.24.1.31 · Cited by 1,632
Calker, D. V., Müller, M., & Hamprecht, B. (1979) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1979.tb05236.x · Cited by 1,371
Krishnamurthi, R. V., Feigin, V. L., Forouzanfar, M. H., Mensah, G. A., Connor, M., Bennett, D. A., Moran, A. E., Sacco, R. L., Anderson, L. M., Truelsen, T., et al. (2013) · The Lancet Global Health · doi:10.1016/s2214-109x(13)70089-5 · Cited by 1,350
Gliotransmitters Travel in Time and Space
Araque, A., Carmignoto, G., Haydon, P. G., Oliet, S. H. R., Robitaille, R., & Volterra, A. (2014) · Neuron · doi:10.1016/j.neuron.2014.02.007 · Cited by 1,308
Fredholm, B. B., IJzerman, A. P., Jacobson, K. A., Linden, J., & Müller, C. E. (2011) · Pharmacological Reviews · doi:10.1124/pr.110.003285 · Cited by 1,301
Astrocytic Purinergic Signaling Coordinates Synaptic Networks
Pascual, O., Casper, K. B., Kubera, C., Zhang, J., Revilla-Sanchez, R., Sul, J.-Y., Takano, H., Moss, S. J., McCarthy, K., & Haydon, P. G. (2005) · Science · doi:10.1126/science.1116916 · Cited by 1,280
Switching of the coupling of the β2-adrenergic receptor to different G proteins by protein kinase A
Daaka, Y., Luttrell, L. M., & Lefkowitz, R. J. (1997) · Nature · doi:10.1038/36362 · Cited by 1,270
Lindsay, J. (2002) · American Journal of Epidemiology · doi:10.1093/aje/kwf074 · Cited by 1,261
Hippocampal synaptic loss in early Alzheimer's disease and mild cognitive impairment
Scheff, S. W., Price, D. A., Schmitt, F. A., & Mufson, E. J. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.09.012 · Cited by 1,017
Cellular function and molecular structure of ecto-nucleotidases
Zimmermann, H., Zebisch, M., & Sträter, N. (2012) · Purinergic Signalling · doi:10.1007/s11302-012-9309-4 · Cited by 977
Brain-derived neurotrophic factor in neurodegenerative diseases
Zuccato, C., & Cattaneo, E. (2009) · Nature Reviews Neurology · doi:10.1038/nrneurol.2009.54 · Cited by 947
Nucleotide signalling during inflammation
Idzko, M., Ferrari, D., & Eltzschig, H. K. (2014) · Nature · doi:10.1038/nature13085 · Cited by 902
Adenosine receptors as drug targets — what are the challenges?
Chen, J.-F., Eltzschig, H. K., & Fredholm, B. B. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd3955 · Cited by 895
SATTIN, A., & RALL, T. W. (1970) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)15197-3 · Cited by 892
Astrocytic Modulation of Sleep Homeostasis and Cognitive Consequences of Sleep Loss
Halassa, M. M., Florian, C., Fellin, T., Munoz, J. R., Lee, S.-Y., Abel, T., Haydon, P. G., & Frank, M. G. (2009) · Neuron · doi:10.1016/j.neuron.2008.11.024 · Cited by 874
Agonist-bound adenosine A2A receptor structures reveal common features of GPCR activation
Lebon, G., Warne, T., Edwards, P. C., Bennett, K., Langmead, C. J., Leslie, A. G. W., & Tate, C. G. (2011) · Nature · doi:10.1038/nature10136 · Cited by 873
Potential therapeutic uses of BDNF in neurological and psychiatric disorders
Nagahara, A. H., & Tuszynski, M. H. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3366 · Cited by 867
Intercellular Calcium Signaling in Astrocytes via ATP Release through Connexin Hemichannels
Stout, C. E., Costantin, J. L., Naus, C. C. G., & Charles, A. C. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109902200 · Cited by 865
Alzheimer's Disease: Molecular Understanding Predicts Amyloid-Based Therapeutics
Selkoe, D. J., & Schenk, D. (2003) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.43.100901.140248 · Cited by 818
ATP receptor-mediated synaptic currents in the central nervous system
Edwards, F. A., Gibb, A. J., & Colquhoun, D. (1992) · Nature · doi:10.1038/359144a0 · Cited by 813
Structure of an Agonist-Bound Human A 2A Adenosine Receptor
Xu, F., Wu, H., Katritch, V., Han, G. W., Jacobson, K. A., Gao, Z.-G., Cherezov, V., & Stevens, R. C. (2011) · Science · doi:10.1126/science.1202793 · Cited by 813
ATP Released from Astrocytes Mediates Glial Calcium Waves
Guthrie, P. B., Knappenberger, J., Segal, M., Bennett, M. V. L., Charles, A. C., & Kater, S. B. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-02-00520.1999 · Cited by 805
Glutamate exocytosis from astrocytes controls synaptic strength
Jourdain, P., Bergersen, L. H., Bhaukaurally, K., Bezzi, P., Santello, M., Domercq, M., Matute, C., Tonello, F., Gundersen, V., & Volterra, A. (2007) · Nature Neuroscience · doi:10.1038/nn1849 · Cited by 801
Ischemic tolerance and endogenous neuroprotection
Dirnagl, U., Simon, R. P., & Hallenbeck, J. M. (2003) · Trends in Neurosciences · doi:10.1016/s0166-2236(03)00071-7 · Cited by 791
Association of coffee and caffeine intake with the risk of Parkinson disease
Ross, G. W. (2000) · JAMA · doi:10.1001/jama.283.20.2674 · Cited by 778
Adenosine in the central nervous system: release mechanisms and extracellular concentrations
Latini, S., & Pedata, F. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00607.x · Cited by 777
Cerebral preconditioning and ischaemic tolerance
Gidday, J. M. (2006) · Nature Reviews Neuroscience · doi:10.1038/nrn1927 · Cited by 751
Sitkovsky, M. V., Lukashev, D., Apasov, S., Kojima, H., Koshiba, M., Caldwell, C., Ohta, A., & Thiel, M. (2004) · Annual Review of Immunology · doi:10.1146/annurev.immunol.22.012703.104731 · Cited by 696
Microglia activation triggers astrocyte-mediated modulation of excitatory neurotransmission
Pascual, O., Ben Achour, S., Rostaing, P., Triller, A., & Bessis, A. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1111098109 · Cited by 693
Fredholm, B. B., Chen, J.-F., Cunha, R. A., Svenningsson, P., & Vaugeois, J.-M. (2005) · International Review of Neurobiology · doi:10.1016/s0074-7742(05)63007-3 · Cited by 692
Self-citationProspective Study of Caffeine Consumption and Risk of Parkinson’s Disease in Men and Women
Ascherio, A., Zhang, S. M., Hernán, M. A., Kawachi, I., Colditz, G. A., Speizer, F. E., & Willett, W. C. (2001) · Annals of Neurology · doi:10.1002/ana.1052 · Cited by 677
Prevalence of Parkinsonian Signs and Associated Mortality in a Community Population of Older People
Bennett, D. A., Beckett, L. A., Murray, A. M., Shannon, K. M., Goetz, C. G., Pilgrim, D. M., & Evans, D. A. (1996) · New England Journal of Medicine · doi:10.1056/nejm199601113340202 · Cited by 659
Cunha, R. A. (2001) · Neurochemistry International · doi:10.1016/s0197-0186(00)00034-6 · Cited by 631
Self-citationATP Released by Astrocytes Mediates Glutamatergic Activity-Dependent Heterosynaptic Suppression
Zhang, J.-M., Wang, H.-K., Ye, C.-Q., Ge, W., Chen, Y., Jiang, Z.-L., Wu, C.-P., Poo, M.-M., & Duan, S. (2003) · Neuron · doi:10.1016/s0896-6273(03)00717-7 · Cited by 630
Ciruela, F., Casadó, V., Rodrigues, R. J., Luján, R., Burgueño, J., Canals, M., Borycz, J., Rebola, N., Goldberg, S. R., Mallol, J., et al. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.3574-05.2006 · Cited by 590
Self-citationTwo distinct adenosine-sensitive sites on adenylate cyclase.
Londos, C., & Wolff, J. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.12.5482 · Cited by 574
The “quad‐partite” synapse: Microglia‐synapse interactions in the developing and mature CNS
Schafer, D. P., Lehrman, E. K., & Stevens, B. (2013) · Glia · doi:10.1002/glia.22389 · Cited by 570
Glial cells in (patho)physiology
Parpura, V., Heneka, M. T., Montana, V., Oliet, S. H. R., Schousboe, A., Haydon, P. G., Stout, R. F., Spray, D. C., Reichenbach, A., Pannicke, T., et al. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2012.07664.x · Cited by 561
A2AAdenosine Receptor Deficiency Attenuates Brain Injury Induced by Transient Focal Ischemia in Mice
Chen, J.-F., Huang, Z., Ma, J., Zhu, J., Moratalla, R., Standaert, D., Moskowitz, M. A., Fink, J. S., & Schwarzschild, M. A. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-21-09192.1999 · Cited by 557
Heurteaux, C., Lauritzen, I., Widmann, C., & Lazdunski, M. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.10.4666 · Cited by 553
Neuroprotection by adenosine in the brain: From A1 receptor activation to A2A receptor blockade
Cunha, R. A. (2005) · Purinergic Signalling · doi:10.1007/s11302-005-0649-1 · Cited by 537
Self-citationRegulated ATP release from astrocytes through lysosome exocytosis
Zhang, Z., Chen, G., Zhou, W., Song, A., Xu, T., Luo, Q., Wang, W., Gu, X.-S., & Duan, S. (2007) · Nature Cell Biology · doi:10.1038/ncb1620 · Cited by 524
Purinergic Signalling: ATP Release
Bodin, P., & Burnstock, G. (2001) · Neurochemical Research · doi:10.1023/a:1012388618693 · Cited by 521
Distribution, biochemistry and function of striatal adenosine A2A receptors
Svenningsson, P. (1999) · Progress in Neurobiology · doi:10.1016/s0301-0082(99)00011-8 · Cited by 516
Adenosine receptors in the nervous system: pathophysiological implications
Ribeiro, J. A., Sebastião, A. M., & de Mendonça, A. (2002) · Progress in Neurobiology · doi:10.1016/s0301-0082(02)00155-7 · Cited by 509
Hillion, J., Canals, M., Torvinen, M., Casadó, V., Scott, R., Terasmaa, A., Hansson, A., Watson, S., Olah, M. E., Mallol, J., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m107731200 · Cited by 500
P2X7 receptor inhibition improves recovery after spinal cord injury
Wang, X., Arcuino, G., Takano, T., Lin, J., Peng, W. G., Wan, P., Li, P., Xu, Q., Liu, Q. S., Goldman, S. A., et al. (2004) · Nature Medicine · doi:10.1038/nm1082 · Cited by 494
Mielke, K., & Herdegen, T. (2000) · Progress in Neurobiology · doi:10.1016/s0301-0082(99)00042-8 · Cited by 490
Storage and Release of ATP from Astrocytes in Culture
Coco, S., Calegari, F., Pravettoni, E., Pozzi, D., Taverna, E., Rosa, P., Matteoli, M., & Verderio, C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209454200 · Cited by 490
Activation of Trk neurotrophin receptors in the absence of neurotrophins
Lee, F. S., & Chao, M. V. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.061020198 · Cited by 482
Thompson, S. M., Haas, H. L., & Gähwiler, B. H. (1992) · The Journal of Physiology · doi:10.1113/jphysiol.1992.sp019168 · Cited by 480
Adenosine: A potential mediator of seizure arrest and postictal refractoriness
During, M. J., & Spencer, D. D. (1992) · Annals of Neurology · doi:10.1002/ana.410320504 · Cited by 476
Mattson, M. P. (2003) · NeuroMolecular Medicine · doi:10.1385/nmm:3:2:65 · Cited by 475
Arendash, G. W., Schleif, W., Rezai-Zadeh, K., Jackson, E. K., Zacharia, L. C., Cracchiolo, J. R., Shippy, D., & Tan, J. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.07.021 · Cited by 457
Signalling via ATP in the nervous system
Zimmermann, H. (1994) · Trends in Neurosciences · doi:10.1016/0166-2236(94)90016-7 · Cited by 437
Targeting adenosine A2A receptors in Parkinson's disease
Schwarzschild, M. A., Agnati, L., Fuxe, K., Chen, J.-F., & Morelli, M. (2006) · Trends in Neurosciences · doi:10.1016/j.tins.2006.09.004 · Cited by 433
Adenosine A2A-Dopamine D2 Receptor-Receptor Heteromerization
Canals, M., Marcellino, D., Fanelli, F., Ciruela, F., de Benedetti, P., Goldberg, S. R., Neve, K., Fuxe, K., Agnati, L. F., Woods, A. S., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m306451200 · Cited by 432
Midlife Coffee and Tea Drinking and the Risk of Late-Life Dementia: A Population-Based CAIDE Study
Eskelinen, M. H., Ngandu, T., Tuomilehto, J., Soininen, H., & Kivipelto, M. (2009) · Journal of Alzheimer's Disease · doi:10.3233/jad-2009-0920 · Cited by 428
Glial Cell Inhibition of Neurons by Release of ATP
Newman, E. A. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-05-01659.2003 · Cited by 426
Adenosine receptors and brain diseases: neuroprotection and neurodegeneration
Gomes, C. V., Kaster, M. P., Tomé, A. R., Agostinho, P. M., & Cunha, R. A. (2011) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2010.12.001 · Cited by 419
Self-citationDunwiddie, T. V., Diao, L., & Proctor, W. R. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-20-07673.1997 · Cited by 413
GABAergic network activation of glial cells underlies hippocampal heterosynaptic depression
Serrano, A., Haddjeri, N., Lacaille, J.-C., & Robitaille, R. (2006) · The Journal of Neuroscience · doi:10.1523/jneurosci.5255-05.2006 · Cited by 398
Adenosine A2A receptors and basal ganglia physiology
Schiffmann, S. N., Fisone, G., Moresco, R., Cunha, R. A., & Ferré, S. (2007) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2007.05.001 · Cited by 397
Self-citationThe role of astroglia in neuroprotection
Bélanger, M., & Magistretti, P. J. (2009) · Dialogues in Clinical Neuroscience · doi:10.31887/dcns.2009.11.3/mbelanger · Cited by 396
Astrocytes in the Epileptic Brain
Wetherington, J., Serrano, G., & Dingledine, R. (2008) · Neuron · doi:10.1016/j.neuron.2008.04.002 · Cited by 389
Rebola, N., Lujan, R., Cunha, R. A., & Mulle, C. (2008) · Neuron · doi:10.1016/j.neuron.2007.11.023 · Cited by 376
Self-citationDall'Igna, O. P., Fett, P., Gomes, M. W., Souza, D. O., Cunha, R. A., & Lara, D. R. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2006.08.008 · Cited by 372
Self-citationFerré, S., Karcz-Kubicha, M., Hope, B. T., Popoli, P., Burgueño, J., Gutiérrez, M. A., Casadó, V., Fuxe, K., Goldberg, S. R., Lluis, C., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.172393799 · Cited by 365
Molecular physiology of p2x receptors and atp signalling at synapses
Khakh, B. S. (2001) · Nature Reviews Neuroscience · doi:10.1038/35058521 · Cited by 363
Adenosine A2A receptor mediates microglial process retraction
Orr, A. G., Orr, A. L., Li, X.-J., Gross, R. E., & Traynelis, S. F. (2009) · Nature Neuroscience · doi:10.1038/nn.2341 · Cited by 362
Canas, P. M., Porciúncula, L. O., Cunha, G. M. A., Silva, C. G., Machado, N. J., Oliveira, J. M. A., Oliveira, C. R., & Cunha, R. A. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.3728-09.2009 · Cited by 357
Self-citationLeWitt, P. A., Guttman, M., Tetrud, J. W., Tuite, P. J., Mori, A., Chaikin, P., Sussman, N. M., & 6002‐US‐005 Study Group (2008) · Annals of Neurology · doi:10.1002/ana.21315 · Cited by 356
Zhang, X., Chen, Y., Wang, C., & Huang, L.-Y. M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611048104 · Cited by 351
Wu, L.-G., & Saggau, P. (1994) · Neuron · doi:10.1016/0896-6273(94)90321-2 · Cited by 348
The neuroprotective effects of caffeine: A prospective population study (the Three City Study)
Ritchie, K., Carrière, I., de Mendonça, A., Portet, F., Dartigues, J. F., Rouaud, O., Barberger-Gateau, P., & Ancelin, M. L. (2007) · Neurology · doi:10.1212/01.wnl.0000266670.35219.0c · Cited by 347
Neuromodulation by Extracellular ATP and P2X Receptors in the CNS
Khakh, B. S., & North, R. A. (2012) · Neuron · doi:10.1016/j.neuron.2012.09.024 · Cited by 341
Release of Adenosine by Activation of NMDA Receptors in the Hippocampus
Manzoni, O. J., Manabe, T., & Nicoll, R. A. (1994) · Science · doi:10.1126/science.7916485 · Cited by 327
Vesicular release of ATP at central synapses
Pankratov, Y., Lalo, U., Verkhratsky, A., & North, R. A. (2006) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-006-0061-x · Cited by 326
A focus on the synapse for neuroprotection in Alzheimer disease and other dementias
Coleman, P., Federoff, H., & Kurlan, R. (2004) · Neurology · doi:10.1212/01.wnl.0000140626.48118.0a · Cited by 314
Kaster, M. P., Machado, N. J., Silva, H. B., Nunes, A., Ardais, A. P., Santana, M., Baqi, Y., Müller, C. E., Rodrigues, A. L. S., Porciúncula, L. O., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1423088112 · Cited by 312
Self-citationBorea, P. A., Gessi, S., Merighi, S., & Varani, K. (2016) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2016.02.006 · Cited by 311
Adenosine Kinase: Exploitation for Therapeutic Gain
Boison, D. (2013) · Pharmacological Reviews · doi:10.1124/pr.112.006361 · Cited by 310
Arendash, G. W., Mori, T., Cao, C., Mamcarz, M., Runfeldt, M., Dickson, A., Rezai-Zadeh, K., Tan, J., Citron, B. A., Lin, X., et al. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-1087 · Cited by 308
Vesicular and conductive mechanisms of nucleotide release
Lazarowski, E. R. (2012) · Purinergic Signalling · doi:10.1007/s11302-012-9304-9 · Cited by 297
Rudolphi, K. A., & Schubert, P. (1995) · Adenosine and Adenine Nucleotides: From Molecular Biology to Integrative Physiology · doi:10.1007/978-1-4615-2011-5_43 · Cited by 294
Astrocytic adenosine receptor A2A and Gs-coupled signaling regulate memory
Orr, A. G., Hsiao, E. C., Wang, M. M., Ho, K., Kim, D. H., Wang, X., Guo, W., Kang, J., Yu, G.-Q., Adame, A., et al. (2015) · Nature Neuroscience · doi:10.1038/nn.3930 · Cited by 289
Astrocyte dysfunction in epilepsy
Seifert, G., Carmignoto, G., & Steinhäuser, C. (2010) · Brain Research Reviews · doi:10.1016/j.brainresrev.2009.10.004 · Cited by 286
Fine-tuning neuromodulation by adenosine
Sebastião, A. (2000) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01517-0 · Cited by 273
Lovatt, D., Xu, Q., Liu, W., Takano, T., Smith, N. A., Schnermann, J., Tieu, K., & Nedergaard, M. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1120997109 · Cited by 273
Mitochondrial Dysfunction and Glutamate Excitotoxicity Studied in Primary Neuronal Cultures
Nicholls, D. (2004) · Current Molecular Medicine · doi:10.2174/1566524043479239 · Cited by 272
Coffee, Caffeine, and Risk of Depression Among Women
Lucas, M. (2011) · Archives of Internal Medicine · doi:10.1001/archinternmed.2011.393 · Cited by 270
Exocytosis of ATP From Astrocytes Modulates Phasic and Tonic Inhibition in the Neocortex
Lalo, U., Palygin, O., Rasooli-Nejad, S., Andrew, J., Haydon, P. G., & Pankratov, Y. (2014) · PLoS Biology · doi:10.1371/journal.pbio.1001747 · Cited by 270
Adenosine receptors: G protein-mediated signalling and the role of accessory proteins
Klinger, M., Freissmuth, M., & Nanoff, C. (2002) · Cellular Signalling · doi:10.1016/s0898-6568(01)00235-2 · Cited by 269
Competitive regulation of synaptic Ca2+ influx by D2 dopamine and A2A adenosine receptors
Higley, M. J., & Sabatini, B. L. (2010) · Nature Neuroscience · doi:10.1038/nn.2592 · Cited by 268
Epigenetic changes induced by adenosine augmentation therapy prevent epileptogenesis
Williams-Karnesky, R. L., Sandau, U. S., Lusardi, T. A., Lytle, N. K., Farrell, J. M., Pritchard, E. M., Kaplan, D. L., & Boison, D. (2013) · Journal of Clinical Investigation · doi:10.1172/jci65636 · Cited by 266
ATP P2XReceptors Mediate Fast Synaptic Transmission in the Dorsal Horn of the Rat Spinal Cord
Bardoni, R., Goldstein, P. A., Lee, C. J., Gu, J. G., & MacDermott, A. B. (1997) · The Journal of Neuroscience · doi:10.1523/jneurosci.17-14-05297.1997 · Cited by 263
Activity-dependent modulation of the BDNF receptor TrkB: mechanisms and implications
Nagappan, G., & Lu, B. (2005) · Trends in Neurosciences · doi:10.1016/j.tins.2005.07.003 · Cited by 263
Adenosine receptor ligands: differences with acute versus chronic treatment
Jacobson, K. A., von Lubitz, D. K. J. E., Daly, J. W., & Fredholm, B. B. (1996) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(96)10002-x · Cited by 263
Inhibition of Toll-like Receptor and Cytokine Signaling—A Unifying Theme in Ischemic Tolerance
Karikó, K., Weissman, D., & Welsh, F. A. (2004) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/01.wcb.0000145666.68576.71 · Cited by 260
Cunha, R. A., Vizi, E. S., Ribeiro, J. A., & Sebastião, A. M. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.67052180.x · Cited by 260
Self-citationCarriba, P., Ortiz, O., Patkar, K., Justinova, Z., Stroik, J., Themann, A., Müller, C., Woods, A. S., Hope, B. T., Ciruela, F., et al. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301375 · Cited by 260
ATP as a multi-target danger signal in the brain
Rodrigues, R. J., Tomé, A. R., & Cunha, R. A. (2015) · Frontiers in Neuroscience · doi:10.3389/fnins.2015.00148 · Cited by 259
Self-citationATP extracellular concentrations are increased in the rat striatum during in vivo ischemia
Melani, A., Turchi, D., Vannucchi, M. G., Cipriani, S., Gianfriddo, M., & Pedata, F. (2005) · Neurochemistry International · doi:10.1016/j.neuint.2005.05.014 · Cited by 258
Neuronal cell death: a demise with different shapes
Nicotera, P., Leist, M., & Manzo, L. (1999) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(99)01304-8 · Cited by 256
Neuroprotective role of astrocytes in cerebral ischemia: Focus on ischemic preconditioning
Trendelenburg, G., & Dirnagl, U. (2005) · Glia · doi:10.1002/glia.20204 · Cited by 256
Toll-like receptor signaling in endogenous neuroprotection and stroke
Marsh, B. J., Williams-Karnesky, R. L., & Stenzel-Poore, M. P. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2008.07.067 · Cited by 255
Neuroprotection by caffeine and adenosine A2A receptor blockade of β‐amyloid neurotoxicity
Dall'lgna, O. P., Porciúncula, L. O., Souza, D. O., Cunha, R. A., & Lara, D. R. (2003) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705185 · Cited by 254
Self-citationDolphin, A. C., Forda, S. R., & Scott, R. H. (1986) · The Journal of Physiology · doi:10.1113/jphysiol.1986.sp016034 · Cited by 254
Cabello, N., Gandía, J., Bertarelli, D. C. G., Watanabe, M., Lluís, C., Franco, R., Ferré, S., Luján, R., & Ciruela, F. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06078.x · Cited by 253
Molecular Physiology of Preconditioning-Induced Brain Tolerance to Ischemia
Obrenovitch, T. P. (2008) · Physiological Reviews · doi:10.1152/physrev.00039.2006 · Cited by 253
Ferre, S., Quiroz, C., Woods, A., Cunha, R., Popoli, P., Ciruela, F., Lluis, C., Franco, R., Azdad, K., & Schiffmann, S. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208784480108 · Cited by 253
Self-citationKoizumi, S., Fujishita, K., Tsuda, M., Shigemoto-Mogami, Y., & Inoue, K. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1834448100 · Cited by 250
Adenosine: does it have a neuroprotective role after all?
de Mendonça, A., Sebastião, A. M., & Ribeiro, J. A. (2000) · Brain Research Reviews · doi:10.1016/s0165-0173(00)00033-3 · Cited by 248
Exocytotic Release of ATP from Cultured Astrocytes
Pangršič, T., Potokar, M., Stenovec, M., Kreft, M., Fabbretti, E., Nistri, A., Pryazhnikov, E., Khiroug, L., Giniatullin, R., & Zorec, R. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m700290200 · Cited by 244
Prediger, R. D. S., Batista, L. C., & Takahashi, R. N. (2005) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2004.08.012 · Cited by 243
Viana da Silva, S., Haberl, M. G., Zhang, P., Bethge, P., Lemos, C., Gonçalves, N., Gorlewicz, A., Malezieux, M., Gonçalves, F. Q., Grosjean, N., et al. (2016) · Nature Communications · doi:10.1038/ncomms11915 · Cited by 242
Self-citationAdenosine kinase, epilepsy and stroke: mechanisms and therapies
Boison, D. (2006) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2006.10.008 · Cited by 241
Stimulation-dependent release of adenosine triphosphate from hippocampal slices
Wieraszko, A., Goldsmith, G., & Seyfried, T. N. (1989) · Brain Research · doi:10.1016/0006-8993(89)90567-2 · Cited by 239
Chen, J.-F., Sonsalla, P. K., Pedata, F., Melani, A., Domenici, M. R., Popoli, P., Geiger, J., Lopes, L. V., & de Mendonça, A. (2007) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2007.09.002 · Cited by 239
Caffeine, Mental Health, and Psychiatric Disorders
Lara, D. R. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-1378 · Cited by 233
The electrophysiology of adenosine in the mammalian central nervous system
Greene, R. W., & Haas, H. L. (1991) · Progress in Neurobiology · doi:10.1016/0301-0082(91)90005-l · Cited by 233
Gomes, C., Ferreira, R., George, J., Sanches, R., Rodrigues, D. I., Gonçalves, N., & Cunha, R. A. (2013) · Journal of Neuroinflammation · doi:10.1186/1742-2094-10-16 · Cited by 233
Self-citationCunha, R. A., & Agostinho, P. M. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-1408 · Cited by 232
Self-citationGrosso, G., Micek, A., Castellano, S., Pajak, A., & Galvano, F. (2016) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201500620 · Cited by 232
Gαolf is necessary for coupling D1 and A2a receptors to adenylyl cyclase in the striatum
Corvol, J. C., Studler, J. M., Schonn, J. S., Girault, J. A., & Hervé, D. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00201.x · Cited by 229
van Gelder, B. M., Buijsse, B., Tijhuis, M., Kalmijn, S., Giampaoli, S., Nissinen, A., & Kromhout, D. (2007) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1602495 · Cited by 228
ATP Release from Affinity‐Purified Rat Cholinergic Nerve Terminals
Richardson, P. J., & Brown, S. J. (1987) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1987.tb04138.x · Cited by 226
Neonatal hepatic steatosis by disruption of the adenosine kinase gene
Boison, D., Scheurer, L., Zumsteg, V., Rülicke, T., Litynski, P., Fowler, B., Brandner, S., & Mohler, H. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.092642899 · Cited by 225
Cyclooxygenase-2 expression in rat microglia is induced by adenosine A2a-receptors
Fiebich, B. L., Biber, K., Lieb, K., Van Calker, D., Berger, M., Bauer, J., & Gebicke-Haerter, P. J. (1996) · Glia · doi:10.1002/(sici)1098-1136(199610)18:2<152::aid-glia7>3.0.co;2-2 · Cited by 225
Release of Adenosine and ATP During Ischemia and Epilepsy
Dale, N., & Frenguelli, B. (2009) · Current Neuropharmacology · doi:10.2174/157015909789152146 · Cited by 224
Frenguelli, B. G., Wigmore, G., Llaudet, E., & Dale, N. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04425.x · Cited by 223
Microglial migration mediated by ATP-induced ATP release from lysosomes
Dou, Y., Wu, H.-J., Li, H.-Q., Qin, S., Wang, Y.-E., Li, J., Lou, H.-F., Chen, Z., Li, X.-M., Luo, Q.-M., et al. (2012) · Cell Research · doi:10.1038/cr.2012.10 · Cited by 223
Lopes, L. V., Cunha, R. A., Kull, B., Fredholm, B. B., & Ribeiro, J. A. (2002) · Neuroscience · doi:10.1016/s0306-4522(02)00080-5 · Cited by 222
Self-citationDysregulation of Protein Kinase A Signaling in the Aged Prefrontal Cortex
Ramos, B. P., Birnbaum, S. G., Lindenmayer, I., Newton, S. S., Duman, R. S., & Arnsten, A. F. T. (2003) · Neuron · doi:10.1016/s0896-6273(03)00694-9 · Cited by 218
Chapter 11 Adenosine and Neuroprotection
Fredholm, B. B. (1996) · International Review of Neurobiology · doi:10.1016/s0074-7742(08)60723-0 · Cited by 217
Cunha, R. A., Sebastião, A. M., & Ribeiro, J. A. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-06-01987.1998 · Cited by 217
Self-citationPurinergic signalling in inflammation of the central nervous system
Di Virgilio, F., Ceruti, S., Bramanti, P., & Abbracchio, M. P. (2009) · Trends in Neurosciences · doi:10.1016/j.tins.2008.11.003 · Cited by 212
Adenosine Receptors and Neurological Disease: Neuroprotection and Neurodegeneration
Stone, T. W., Ceruti, S., & Abbracchio, M. P. (2009) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-540-89615-9_17 · Cited by 211
Serchov, T., Clement, H.-W., Schwarz, M. K., Iasevoli, F., Tosh, D. K., Idzko, M., Jacobson, K. A., de Bartolomeis, A., Normann, C., Biber, K., et al. (2015) · Neuron · doi:10.1016/j.neuron.2015.07.010 · Cited by 210
Ectonucleotidases in the Nervous System
Zimmermann, H. (2006) · Novartis Foundation Symposia · doi:10.1002/9780470032244.ch10 · Cited by 209
Florian, C., Vecsey, C. G., Halassa, M. M., Haydon, P. G., & Abel, T. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.5761-10.2011 · Cited by 209
Huntington's disease: a synaptopathy?
Li, J.-Y., Plomann, M., & Brundin, P. (2003) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2003.08.006 · Cited by 208
Study of istradefylline in patients with Parkinson's disease on levodopa with motor fluctuations
Hauser, R. A., Shulman, L. M., Trugman, J. M., Roberts, J. W., Mori, A., Ballerini, R., & Sussman, N. M. (2008) · Movement Disorders · doi:10.1002/mds.22095 · Cited by 207
Effects of coffee/caffeine on brain health and disease: What should I tell my patients?
Nehlig, A. (2016) · Practical Neurology · doi:10.1136/practneurol-2015-001162 · Cited by 205
Synaptic Vulnerability in Neurodegenerative Disease
Wishart, T. M., Parson, S. H., & Gillingwater, T. H. (2006) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/01.jnen.0000228202.35163.c4 · Cited by 204
Rebola, N., Canas, P. M., Oliveira, C. R., & Cunha, R. A. (2005) · Neuroscience · doi:10.1016/j.neuroscience.2005.01.014 · Cited by 202
Self-citationDing, M., Satija, A., Bhupathiraju, S. N., Hu, Y., Sun, Q., Han, J., Lopez-Garcia, E., Willett, W., van Dam, R. M., & Hu, F. B. (2015) · Circulation · doi:10.1161/circulationaha.115.017341 · Cited by 202
Pathophysiology of astroglial purinergic signalling
Franke, H., Verkhratsky, A., Burnstock, G., & Illes, P. (2012) · Purinergic Signalling · doi:10.1007/s11302-012-9300-0 · Cited by 201
Adenosine dysfunction in epilepsy
Boison, D. (2012) · Glia · doi:10.1002/glia.22285 · Cited by 200
Monopoli, A., Lozza, G., Forlani, A., Mattavelli, A., & Ongini, E. (1998) · NeuroReport · doi:10.1097/00001756-199812010-00034 · Cited by 200
Vesicular ATP Is the Predominant Cause of Intercellular Calcium Waves in Astrocytes
Bowser, D. N., & Khakh, B. S. (2007) · The Journal of General Physiology · doi:10.1085/jgp.200709780 · Cited by 199
ATP as a presynaptic modulator
Cunha, R. A., & Ribeiro, J. A. (2000) · Life Sciences · doi:10.1016/s0024-3205(00)00923-1 · Cited by 197
Self-citationCoffee Consumption and Risk of Stroke: A Dose-Response Meta-Analysis of Prospective Studies
Larsson, S. C., & Orsini, N. (2011) · American Journal of Epidemiology · doi:10.1093/aje/kwr226 · Cited by 196 · cited 1×
“…injury (Sachse et al. 2008) or attention deficit and hyperactivity disorder (ADHD) (Gross 1975; Garfinkel et al. 1981) and risk to develop brain stroke (Larsson and Orsini 2011; Larsson et al. 2011), depression (Smith 2009; Ruusunen et al. 2010; Lucas et al. 2011; Guo et al. 2014; Pham et al.…”
BackgroundMitchell, J., Lupica, C., & Dunwiddie, T. (1993) · The Journal of Neuroscience · doi:10.1523/jneurosci.13-08-03439.1993 · Cited by 196
Adenosine A2A receptors control neuroinflammation and consequent hippocampal neuronal dysfunction
Rebola, N., Simões, A. P., Canas, P. M., Tomé, A. R., Andrade, G. M., Barry, C. E., Agostinho, P. M., Lynch, M. A., & Cunha, R. A. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07178.x · Cited by 196
Self-citationRodrigues, R. J., Alfaro, T. M., Rebola, N., Oliveira, C. R., & Cunha, R. A. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02887.x · Cited by 196
Self-citationAdenosine A2AReceptors are Colocalized with and Activate Golfin Rat Striatum
Kull, B., Svenningsson, P., & Fredholm, B. B. (2000) · Molecular Pharmacology · doi:10.1124/mol.58.4.771 · Cited by 196
Beneficial effects of caffeine in a transgenic model of Alzheimer's disease-like tau pathology
Laurent, C., Eddarkaoui, S., Derisbourg, M., Leboucher, A., Demeyer, D., Carrier, S., Schneider, M., Hamdane, M., Müller, C. E., Buée, L., et al. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.03.027 · Cited by 195
Sexl, V., Mancusi, G., Höller, C., Gloria-Maercker, E., Schütz, W., & Freissmuth, M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.9.5792 · Cited by 194
Caffeine Intake and Dementia: Systematic Review and Meta-Analysis
Santos, C., Costa, J., Santos, J., Vaz-Carneiro, A., & Lunet, N. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-091387 · Cited by 192
Ciruela, F., Burgueño, J., Casadó, V., Canals, M., Marcellino, D., Goldberg, S. R., Bader, M., Fuxe, K., Agnati, L. F., Lluis, C., et al. (2004) · Analytical Chemistry · doi:10.1021/ac049295f · Cited by 192
Past, present and future of A2A adenosine receptor antagonists in the therapy of Parkinson's disease
Armentero, M. T., Pinna, A., Ferré, S., Lanciego, J. L., Müller, C. E., & Franco, R. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.07.004 · Cited by 192
Lopes, L. V., Cunha, R. A., & Ribeiro, J. A. (1999) · Journal of Neurophysiology · doi:10.1152/jn.1999.82.6.3196 · Cited by 191
Self-citationAspects of the general biology of adenosine A2A signaling
Fredholm, B. B., Chern, Y., Franco, R., & Sitkovsky, M. (2007) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2007.07.005 · Cited by 190
ATP: A ubiquitous gliotransmitter integrating neuron–glial networks
Butt, A. M. (2011) · Seminars in Cell & Developmental Biology · doi:10.1016/j.semcdb.2011.02.023 · Cited by 189
A2A adenosine receptor deletion is protective in a mouse model of Tauopathy
Laurent, C., Burnouf, S., Ferry, B., Batalha, V. L., Coelho, J. E., Baqi, Y., Malik, E., Mariciniak, E., Parrot, S., Van der Jeugd, A., et al. (2016) · Molecular Psychiatry · doi:10.1038/mp.2014.151 · Cited by 188
Adenosine A2A receptor stimulation potentiates nitric oxide release by activated microglia
Saura, J., Angulo-Pueyo, E., Ejarque-Ortiz, A., Casadó, V., Tusell, J. M., Moratalla, R., Chen, J., Schwarzschild, M. A., Lluís, C., Franco, R., et al. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03395.x · Cited by 188
Comparison of CGS 15943, ZM 241385 and SCH 58261 as antagonists at human adenosine receptors
Ongini, E., Dionisotti, S., Gessi, S., Irenius, E., & Fredholm, B. B. (1999) · Naunyn-Schmiedeberg's Archives of Pharmacology · doi:10.1007/pl00005326 · Cited by 187
Potential Therapeutic Interest of Adenosine A2A Receptors in Psychiatric Disorders
Cunha, R., Ferre, S., Vaugeois, J.-M., & Chen, J.-F. (2008) · Current Pharmaceutical Design · doi:10.2174/138161208784480090 · Cited by 186
Self-citationCaffeine and risk of Parkinson’s disease in a large cohort of men and women
Palacios, N., Gao, X., McCullough, M. L., Schwarzschild, M. A., Shah, R., Gapstur, S., & Ascherio, A. (2012) · Movement Disorders · doi:10.1002/mds.25076 · Cited by 185
Azdad, K., Gall, D., Woods, A. S., Ledent, C., Ferré, S., & Schiffmann, S. N. (2009) · Neuropsychopharmacology · doi:10.1038/npp.2008.144 · Cited by 185
Kochanek, P. M., Vagni, V. A., Janesko, K. L., Washington, C. B., Crumrine, P. K., Garman, R. H., Jenkins, L. W., Clark, R. S., Homanics, G. E., Dixon, C. E., et al. (2006) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600218 · Cited by 185
Koizumi, S., Ohsawa, K., Inoue, K., & Kohsaka, S. (2013) · Glia · doi:10.1002/glia.22358 · Cited by 184
Adenosine inhibits excitatory but not inhibitory synaptic transmission in the hippocampus
Yoon, K., & Rothman, S. (1991) · The Journal of Neuroscience · doi:10.1523/jneurosci.11-05-01375.1991 · Cited by 183
Prospective study of coffee consumption and risk of Parkinson’s disease
Sääksjärvi, K., Knekt, P., Rissanen, H., Laaksonen, M. A., Reunanen, A., & Männistö, S. (2008) · European Journal of Clinical Nutrition · doi:10.1038/sj.ejcn.1602788 · Cited by 182
FGF acts as a co-transmitter through adenosine A2A receptor to regulate synaptic plasticity
Flajolet, M., Wang, Z., Futter, M., Shen, W., Nuangchamnong, N., Bendor, J., Wallach, I., Nairn, A. C., Surmeier, D. J., & Greengard, P. (2008) · Nature Neuroscience · doi:10.1038/nn.2216 · Cited by 182
Depression as a Glial-Based Synaptic Dysfunction
Rial, D., Lemos, C., Pinheiro, H., Duarte, J. M., Gonçalves, F. Q., Real, J. I., Prediger, R. D., Gonçalves, N., Gomes, C. A., Canas, P. M., et al. (2016) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00521 · Cited by 182
Self-citationCoffee and caffeine consumption and depression: a meta-analysis of observational studies
Wang, L., Shen, X., Wu, Y., & Zhang, D. (2016) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/0004867415603131 · Cited by 180
Costenla, A. R., Diógenes, M. J., Canas, P. M., Rodrigues, R. J., Nogueira, C., Maroco, J., Agostinho, P. M., Ribeiro, J. A., Cunha, R. A., & de Mendonça, A. (2011) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2011.07719.x · Cited by 178
Self-citationMori, M., Heuss, C., Gähwiler, B. H., & Gerber, U. R. (2001) · The Journal of Physiology · doi:10.1111/j.1469-7793.2001.t01-1-00115.x · Cited by 178
RESEARCH ARTICLE: Up‐regulation of Adenosine Receptors in the Frontal Cortex in Alzheimer's Disease
Albasanz, J. L., Perez, S., Barrachina, M., Ferrer, I., & Martín, M. (2008) · Brain Pathology · doi:10.1111/j.1750-3639.2007.00112.x · Cited by 177
Adenosine receptor antagonists including caffeine alter fetal brain development in mice
Silva, C. G., Métin, C., Fazeli, W., Machado, N. J., Darmopil, S., Launay, P.-S., Ghestem, A., Nesa, M.-P., Bassot, E., Szabó, E., et al. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3006258 · Cited by 177
Self-citationAdenosinergic cardioprotection: Multiple receptors, multiple pathways
Peart, J. N., & Headrick, J. P. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2007.02.004 · Cited by 175
Adenosine and cerebral ischemia: therapeutic future or death of a brave concept?
von Lubitz, D. K. J. E. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00135-1 · Cited by 175
GPCR Interacting Proteins (GIPs) in the Nervous System: Roles in Physiology and Pathologies
Bockaert, J., Perroy, J., Bécamel, C., Marin, P., & Fagni, L. (2010) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.010909.105705 · Cited by 175
Adenosine receptor antagonists for cognitive dysfunction: a review of animal studies
Takahashi, R. N. (2008) · Frontiers in Bioscience · doi:10.2741/2870 · Cited by 174
Diógenes, M. J., Fernandes, C. C., Sebastião, A. M., & Ribeiro, J. A. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.4454-03.2004 · Cited by 172
Braun, N., Zhu, Y., Krieglstein, J., Culmsee, C., & Zimmermann, H. (1998) · The Journal of Neuroscience · doi:10.1523/jneurosci.18-13-04891.1998 · Cited by 172
Adenosine A1 receptors are crucial in keeping an epileptic focus localized
Fedele, D. E., Li, T., Lan, J. Q., Fredholm, B. B., & Boison, D. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2006.02.133 · Cited by 170
Lupica, C. R., Cass, W. A., Zahniser, N. R., & Dunwiddie, T. V. (1990) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20171-9 · Cited by 169
Lloyd, H., Lindström, K., & Fredholm, B. B. (1993) · Neurochemistry International · doi:10.1016/0197-0186(93)90095-m · Cited by 169
Cited by
Pharmacology of Adenosine Receptors: The State of the Art
Borea, P. A., Gessi, S., Merighi, S., Vincenzi, F., & Varani, K. (2018) · Physiological Reviews · doi:10.1152/physrev.00049.2017 · Cited by 783
Interindividual Differences in Caffeine Metabolism and Factors Driving Caffeine Consumption
Nehlig, A. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.014407 · Cited by 632
The adenosine pathway in immuno-oncology
Allard, B., Allard, D., Buisseret, L., & Stagg, J. (2020) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-020-0382-2 · Cited by 586
Purinergic Signalling: Therapeutic Developments
Burnstock, G. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00661 · Cited by 398
Mental Fatigue Impairs Endurance Performance: A Physiological Explanation
Martin, K., Meeusen, R., Thompson, K. G., Keegan, R., & Rattray, B. (2018) · Sports Medicine · doi:10.1007/s40279-018-0946-9 · Cited by 257
Metadata
- Authors
- Cunha, R. A.
- Venue
- Journal of Neurochemistry
- Publisher
- Wiley
- Published
- 2016-08-16
- Volume
- 139
- Issue
- 6
- Pages
- 1019-1055
- ISSN
- 0022-3042 (ISSN-L)
- 1471-4159
- OpenAlex
- W2472172082
- Cited by
- 441
- References
- 642
- FWCI
- 30.80
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.